Stock Track | CVS Health Soars 5% as Aetna Turnaround Boosts 2025 Outlook

Stock Track

02-14

CVS Health Corp. (NYSE: CVS) stock surged over 5% in pre-market trading on Thursday as the healthcare giant provided an upbeat outlook for 2025, driven by the expected recovery in its Aetna health insurance business.

The company reported mixed results for the fourth quarter of 2024, with revenue of $97.71 billion beating estimates but adjusted earnings per share (EPS) of $1.19 falling short due to continued pressure in the Healthcare Benefits segment. However, CVS Health expressed confidence in its future performance, forecasting 2025 adjusted EPS of $5.75 to $6.00, which represents a significant improvement over the previous year.

The key driver behind this optimism is the anticipated turnaround in Aetna's operations, particularly in the lucrative Medicare Advantage market. CVS Health's new CEO, David Joyner, highlighted the company's "deliberate approach" to Medicare Advantage bids and improved star ratings, which are expected to boost margins in this segment.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1182521383"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1182521383\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1182521383?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-14 02:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182521383","market":"us","top_or_hot":-1,"title":"Stock Track | CVS Health Soars 5% as Aetna Turnaround Boosts 2025 Outlook","media":"Stock Track","content":"<p>CVS Health Corp. (NYSE: CVS) stock surged over 5% in pre-market trading on Thursday as the healthcare giant provided an upbeat outlook for 2025, driven by the expected recovery in its Aetna health insurance business.</p>\n\n<p>The company reported mixed results for the fourth quarter of 2024, with revenue of $97.71 billion beating estimates but adjusted earnings per share (EPS) of $1.19 falling short due to continued pressure in the Healthcare Benefits segment. However, CVS Health expressed confidence in its future performance, forecasting 2025 adjusted EPS of $5.75 to $6.00, which represents a significant improvement over the previous year.</p>\n\n<p>The key driver behind this optimism is the anticipated turnaround in Aetna's operations, particularly in the lucrative Medicare Advantage market. CVS Health's new CEO, David Joyner, highlighted the company's \"deliberate approach\" to Medicare Advantage bids and improved star ratings, which are expected to boost margins in this segment.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CVS Health Soars 5% as Aetna Turnaround Boosts 2025 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CVS Health Soars 5% as Aetna Turnaround Boosts 2025 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-14 02:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CVS Health Corp. (NYSE: CVS) stock surged over 5% in pre-market trading on Thursday as the healthcare giant provided an upbeat outlook for 2025, driven by the expected recovery in its Aetna health insurance business.</p>\n\n<p>The company reported mixed results for the fourth quarter of 2024, with revenue of $97.71 billion beating estimates but adjusted earnings per share (EPS) of $1.19 falling short due to continued pressure in the Healthcare Benefits segment. However, CVS Health expressed confidence in its future performance, forecasting 2025 adjusted EPS of $5.75 to $6.00, which represents a significant improvement over the previous year.</p>\n\n<p>The key driver behind this optimism is the anticipated turnaround in Aetna's operations, particularly in the lucrative Medicare Advantage market. CVS Health's new CEO, David Joyner, highlighted the company's \"deliberate approach\" to Medicare Advantage bids and improved star ratings, which are expected to boost margins in this segment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CVS","symbol_name":"西维斯健康","start_time":0,"source_url":"","article_id":"1182521383","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182521383","pubTimestamp":1739471377,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"CVS Health Corp.  stock surged over 5% in pre-market trading on Thursday as the healthcare giant provided an upbeat outlook for 2025, driven by the expected recovery in its Aetna health insurance business.The company reported mixed results for the fourth quarter of 2024, with revenue of $97.71 billion beating estimates but adjusted earnings per share  of $1.19 falling short due to continued pressure in the Healthcare Benefits segment. However, CVS Health expressed confidence in its future perfor","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CVS":"西维斯健康"},"translate_title":"Aetna扭亏为盈提振2025年前景，股票跟踪CVS Health飙升5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CVS":1},"content_text":"CVS Health Corp. (NYSE: CVS) stock surged over 5% in pre-market trading on Thursday as the healthcare giant provided an upbeat outlook for 2025, driven by the expected recovery in its Aetna health insurance business.\nThe company reported mixed results for the fourth quarter of 2024, with revenue of $97.71 billion beating estimates but adjusted earnings per share (EPS) of $1.19 falling short due to continued pressure in the Healthcare Benefits segment. However, CVS Health expressed confidence in its future performance, forecasting 2025 adjusted EPS of $5.75 to $6.00, which represents a significant improvement over the previous year.\nThe key driver behind this optimism is the anticipated turnaround in Aetna's operations, particularly in the lucrative Medicare Advantage market. CVS Health's new CEO, David Joyner, highlighted the company's \"deliberate approach\" to Medicare Advantage bids and improved star ratings, which are expected to boost margins in this segment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1}}}